A share price of scPharmaceuticals Inc [SCPH] is currently trading at $2.58, up 11.21%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SCPH shares have gain 10.73% over the last week, with a monthly amount drifted -14.85%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
scPharmaceuticals Inc [NASDAQ: SCPH] stock has seen the most recent analyst activity on September 07, 2023, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $20. Previously, Cowen started tracking the stock with Outperform rating on December 01, 2022, and set its price target to $25. SVB Leerink upgraded its rating to a Outperform but stick to its price target of $11 on October 11, 2022. Maxim Group initiated its recommendation with a Buy and recommended $10 as its price target on August 02, 2022. SVB Leerink started tracking with a Mkt Perform rating for this stock on September 09, 2021, and assigned it a price target of $6. In a note dated October 15, 2019, H.C. Wainwright initiated an Buy rating and provided a target price of $13 on this stock.
scPharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $1.94 and $5.65. Currently, Wall Street analysts expect the stock to reach $13 within the next 12 months. scPharmaceuticals Inc [NASDAQ: SCPH] shares were valued at $2.58 at the most recent close of the market. An investor can expect a potential return of 403.88% based on the average SCPH price forecast.
Analyzing the SCPH fundamentals
Trailing Twelve Months sales for scPharmaceuticals Inc [NASDAQ:SCPH] were 36.33M which represents 99.31% growth. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at -1.78%, Pretax Profit Margin comes in at -2.34%, and Net Profit Margin reading is -2.34%. To continue investigating profitability, this company’s Return on Assets is posted at -0.79, Equity is -4.38 and Total Capital is -0.7. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of3.96.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.35 points at the first support level, and at 2.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.70, and for the 2nd resistance point, it is at 2.82.
Ratios To Look Out For
To put it in perspective, the Current Ratio for scPharmaceuticals Inc [NASDAQ:SCPH] is 7.12. As well, the Quick Ratio is 6.18, while the Cash Ratio is 5.09. Considering the valuation of this stock, the price to sales ratio is 3.57, the price to book ratio is 9.70.
Transactions by insiders
Recent insider trading involved ORBIMED ADVISORS LLC, 10% Owner, that happened on Aug 13 ’24 when 0.5 million shares were purchased.
